Anti-dementia drugs and hippocampal-dependent memory in rodents
- PMID: 17762506
- PMCID: PMC2666934
- DOI: 10.1097/FBP.0b013e3282da278d
Anti-dementia drugs and hippocampal-dependent memory in rodents
Abstract
Abnormalities in hippocampal structure and function are characteristics of early Alzheimer's disease (AD). Behavioral tests measuring hippocampal-dependent memory in rodents are often used to evaluate novel treatments for AD and other dementias. In this study, we review the effects of drugs marketed for the treatment of AD, such as the acetylcholinesterase inhibitors, donepezil, rivastigmine, galantamine and the N-methyl-D-aspartic acid antagonist, memantine, in rodent models of memory impairment. We also briefly describe the effects of novel treatments for cognitive impairment in rodent models of memory impairment, and discuss issues concerning the selection of the animal model and behavioral tests. Suggestions for future research are offered.
References
-
- Abe Y, Aoyaqui A, Hara T, Abe K, Yamazaki R, Kumagae Y, et al. Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease. J Pharmacol Sci. 2003;93:95–105. - PubMed
-
- Areosa SA, Sherriff F, McShane R. Memantine for dementia. Cochrane Database Syst Rev. 2005;3:CD003154. - PubMed
-
- Aggleton JP, Hunt PR, Rawlins JNP. The effects of hippocampal lesions upon spatial and non-spatial tests of working memory. Behav Brain Res. 1986;19:133–146. - PubMed
-
- Alzheimer A. On a peculiar disease of the cerebral cortex. Zr Psychiatrie. 1907;64:146.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical